“Biosimilars” are equivalent versions of monoclonal antibodies that have previously been FDA approved to treat various diseases. Because antibodies are...
By Panagiotis Baliakas, MD, PhD
Introduction
For chronic lymphocytic leukemia patients, there is no dearth of things to worry about, especially when...
